Novo Nordisk | NVO - EPS Earnings Per Share



Novo Nordisk reported DKK12.49 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 0.93 0.91 4.49 Aug/06 2025
FY2025Q1 Mar/2025 6.53 0.90 5.68 May/07 2025
FY2024Q4 Dec/2024 6.34 0.88 0.72 Feb/05 2025
FY2024Q3 Sep/2024 6.12 0.88 5.00 Nov/06 2024
FY2024Q2 Jun/2024 4.49 4.32 Aug/07 2024
FY2024Q1 Mar/2024 5.68 4.39 May/02 2024
FY2023Q4 Dec/2023 0.72 0.67 6.02 Jan/31 2024
FY2023Q3 Sep/2023 5.00 0.68 6.34 Nov/02 2023
FY2023Q2 Jun/2023 8.71 4.45 2.93 Sep/11 2023
FY2023Q1 Mar/2023 8.78 8.58 3.11 May/04 2023
FY2022Q4 Dec/2022 6.02 6.02 4.76 Feb/01 2023
FY2022Q3 Sep/2022 6.34 6.32 5.27 Nov/02 2022


Eps Change Date
ANI Pharmaceuticals USD 1.8 0.1 Jun/2025
Aurora Cannabis CAD -0.26 0.84 Jun/2025
Bausch Health Companies USD 1.05 0.37 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Canopy Growth CAD -0.22 0.89 Jun/2025
Corcept Therapeutics USD 0.29 0.12 Jun/2025
Drreddys Laboratories INR 17.02 0.08 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
GlaxoSmithKline GBP 0.47 0.02 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Novo Nordisk 5.96 0.57 Jun/2025
Novo Nordisk DKK 12.49 5.96 Jun/2025
Pacira USD 0.74 0.12 Jun/2025
Perrigo USD 0.57 0.03 Jun/2025
Prestige Brands USD 0.95 0.05 Jun/2025
Sanofi EUR 1.59 0.21 Jun/2025
Supernus Pharmaceuticals USD 0.4 0.61 Jun/2025
Zoetis USD 1.76 0.28 Jun/2025